ArticleBiodegradation2025
Biodegradation of lignocellulosic wastes by thermotolerant cellulolytic actinomycetal consortium isolated from Uhud Mountain, Madinah, Saudi Arabia.
Article in Biodegradation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Green biocatalysis: Box-Behnken-optimized cellulase from thermophilic Streptomyces griseorubens NBR14 for waste management and dye removal.Biodegradation · 2026Article
- Fungal-bacterial interaction networks in lignocellulose degradation: an integrated ecological and mechanistic perspective.Biotechnology for biofuels and bioproducts · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The actinomycetal consortium plays a key role in lignocellulose degradation and offers promising applications in sustainable biomass conversion and biotechnology. A thermotolerant lignocellulolytic actinobacterial consortium, composed of strains A5 (Streptomyces cavourensis strain QT227), C13 (Streptomyces parvus 5-94 gene), and C17 (Streptomyces cavourensis strain SIF3) isolated from an arid region in Madinah, Saudi Arabia, demonstrates significant potential in sustainable biomass conversion and biotechnology. This consortium effectively degrades various cellulosic substrates, including bagasse (SB), corncob (CC), and palm leaves (PL), making it suitable for biorefinery processes. Specifically, the consortium achieved saccharification percentages of 159% for CC, 96.2% for SB, and 37.02% for PL. Correspondingly, the utilization percentages for these substrates were 37% for CC, 11% for SB, and 17% for PL. The consortium's crude extract exhibited total cellulase activities of 1.34 U/mL on CC, 1.51 U/mL on SB, and 0.42 U/mL on PL. The kinetic parameters of CMCase activity were determined for individual strains A5, C13, and C17, with affinity (K
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.